Logo image of SCANA.OL

SCANA ASA (SCANA.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:SCANA - NO0003053308 - Common Stock

1.448 NOK
-0.01 (-0.69%)
Last: 12/10/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, SCANA scores 3 out of 10 in our fundamental rating. SCANA was compared to 109 industry peers in the Machinery industry. SCANA has a medium profitability rating, but doesn't score so well on its financial health evaluation. SCANA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SCANA had positive earnings in the past year.
SCANA had a positive operating cash flow in the past year.
Of the past 5 years SCANA 4 years were profitable.
Each year in the past 5 years SCANA had a positive operating cash flow.
SCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.43%, SCANA is doing worse than 79.82% of the companies in the same industry.
With a Return On Equity value of -8.91%, SCANA is not doing good in the industry: 78.90% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.43%
ROE -8.91%
ROIC N/A
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
SCANA.OL Yearly ROA, ROE, ROICSCANA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

SCANA's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of SCANA has grown nicely.
SCANA has a better Gross Margin (56.32%) than 76.15% of its industry peers.
SCANA's Gross Margin has improved in the last couple of years.
SCANA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.32%
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
SCANA.OL Yearly Profit, Operating, Gross MarginsSCANA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1

2. Health

2.1 Basic Checks

SCANA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SCANA has been increased compared to 1 year ago.
SCANA has more shares outstanding than it did 5 years ago.
SCANA has a better debt/assets ratio than last year.
SCANA.OL Yearly Shares OutstandingSCANA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SCANA.OL Yearly Total Debt VS Total AssetsSCANA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of SCANA is 6.34, which is on the high side as it means it would take SCANA, 6.34 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 6.34, SCANA perfoms like the industry average, outperforming 46.79% of the companies in the same industry.
A Debt/Equity ratio of 0.60 indicates that SCANA is somewhat dependend on debt financing.
The Debt to Equity ratio of SCANA (0.60) is worse than 61.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 6.34
Altman-Z N/A
ROIC/WACCN/A
WACC8.53%
SCANA.OL Yearly LT Debt VS Equity VS FCFSCANA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SCANA has a Current Ratio of 0.95. This is a bad value and indicates that SCANA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SCANA (0.95) is worse than 87.16% of its industry peers.
A Quick Ratio of 0.79 indicates that SCANA may have some problems paying its short term obligations.
The Quick ratio of SCANA (0.79) is worse than 70.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.79
SCANA.OL Yearly Current Assets VS Current LiabilitesSCANA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

SCANA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.23%, which is quite good.
Measured over the past years, SCANA shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.20% on average per year.
The Revenue has grown by 19.82% in the past year. This is quite good.
The Revenue has been growing by 39.74% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.23%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-100%
Revenue 1Y (TTM)19.82%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-12.18%

3.2 Future

SCANA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.20% yearly.
The Revenue is expected to decrease by -1.05% on average over the next years.
EPS Next Y-118.84%
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%
EPS Next 5YN/A
Revenue Next Year-16.87%
Revenue Next 2Y-4.58%
Revenue Next 3Y-1.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SCANA.OL Yearly Revenue VS EstimatesSCANA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
SCANA.OL Yearly EPS VS EstimatesSCANA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.05, which indicates a very decent valuation of SCANA.
Compared to the rest of the industry, the Price/Earnings ratio of SCANA indicates a rather cheap valuation: SCANA is cheaper than 94.50% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SCANA to the average of the S&P500 Index (26.59), we can say SCANA is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 14.06, the valuation of SCANA can be described as correct.
64.22% of the companies in the same industry are more expensive than SCANA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.80. SCANA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 9.05
Fwd PE 14.06
SCANA.OL Price Earnings VS Forward Price EarningsSCANA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SCANA indicates a slightly more expensive valuation: SCANA is more expensive than 61.47% of the companies listed in the same industry.
SCANA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SCANA is cheaper than 82.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.71
EV/EBITDA 14.27
SCANA.OL Per share dataSCANA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

SCANA's earnings are expected to decrease with -4.20% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.43
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%

0

5. Dividend

5.1 Amount

SCANA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SCANA ASA

OSL:SCANA (12/10/2025, 7:00:00 PM)

1.448

-0.01 (-0.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners1.24%
Inst Owner ChangeN/A
Ins Owners10.16%
Ins Owner ChangeN/A
Market Cap668.82M
Revenue(TTM)1.92B
Net Income(TTM)-54.30M
Analysts86.67
Price Target1.94 (33.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)-61.68%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-8.4%
Min Revenue beat(2)-19.55%
Max Revenue beat(2)2.75%
Revenue beat(4)2
Avg Revenue beat(4)-6.93%
Min Revenue beat(4)-19.55%
Max Revenue beat(4)2.75%
Revenue beat(8)4
Avg Revenue beat(8)-0.82%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.05
Fwd PE 14.06
P/S 0.41
P/FCF 7.71
P/OCF 4
P/B 1.1
P/tB 2.94
EV/EBITDA 14.27
EPS(TTM)0.16
EY11.05%
EPS(NY)0.1
Fwd EY7.11%
FCF(TTM)0.19
FCFY12.96%
OCF(TTM)0.36
OCFY25%
SpS3.57
BVpS1.32
TBVpS0.49
PEG (NY)N/A
PEG (5Y)0.43
Graham Number2.18
Profitability
Industry RankSector Rank
ROA -3.43%
ROE -8.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.32%
FCFM 5.26%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 6.34
Debt/EBITDA 4.33
Cap/Depr 68.92%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion 196.94%
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.79
Altman-Z N/A
F-Score4
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)42.24%
Cap/Depr(5y)32.52%
Cap/Sales(3y)2.81%
Cap/Sales(5y)1.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.23%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-100%
EPS Next Y-118.84%
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%
EPS Next 5YN/A
Revenue 1Y (TTM)19.82%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-12.18%
Revenue Next Year-16.87%
Revenue Next 2Y-4.58%
Revenue Next 3Y-1.05%
Revenue Next 5YN/A
EBIT growth 1Y-121.24%
EBIT growth 3Y125.68%
EBIT growth 5Y359.05%
EBIT Next Year-10.22%
EBIT Next 3Y16.57%
EBIT Next 5YN/A
FCF growth 1Y-5.56%
FCF growth 3Y41.29%
FCF growth 5Y3.96%
OCF growth 1Y49.17%
OCF growth 3Y80.15%
OCF growth 5Y20.9%

SCANA ASA / SCANA.OL FAQ

What is the fundamental rating for SCANA stock?

ChartMill assigns a fundamental rating of 3 / 10 to SCANA.OL.


What is the valuation status of SCANA ASA (SCANA.OL) stock?

ChartMill assigns a valuation rating of 5 / 10 to SCANA ASA (SCANA.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for SCANA ASA?

SCANA ASA (SCANA.OL) has a profitability rating of 4 / 10.


What is the valuation of SCANA ASA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SCANA ASA (SCANA.OL) is 9.05 and the Price/Book (PB) ratio is 1.1.


How financially healthy is SCANA ASA?

The financial health rating of SCANA ASA (SCANA.OL) is 1 / 10.